ArticleNature medicine2018

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

Nimitha R Mathew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.